What do we know about the consistency of the results for empagliflozin across the spectrum of ejection fraction? from Let's Talk! - Dr. James Januzzi

Click on the timestamp to jump to the topic you are interested in.

• 00:20 Consistent results of empagliflozin 00:50 Empagliflozin significantly reduced the risk of CV death or HHF across the LVEF spectrum 01:23 Early benefits with empagliflozin observed in the EMPEROR-Reduced and EMPEROR-Preserved trials 01:48 LVEF did not impact the effect of empagliflozin on CV death or first HHF